Price movement over the last 24 hours
AbCellera Biologics Inc vs Wix.Com Ltd — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Wix.Com Ltd trades at $47.53 (market cap $2.11B). The key difference: AbCellera Biologics Inc and Wix.Com Ltd are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals.
| ABCL | WIX | |
|---|---|---|
Market Cap | $2.35B | $2.11B |
Sector | Health | Technology |
52-Week High | $8.12 | $184.24 |
52-Week Low | $2.78 | $40.43 |
Enterprise Value | $1.99B | $1.67B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →